Shanghai Allist Pharmaceuticals Lifts Q3 Profit by 40.4% Annually
Shanghai Allist Pharmaceuticals reported third-quarter net profit up 40.4% year on year, according to a Reuters report on the company's filing.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Shanghai Allist Pharmaceuticals said its net profit rose 40.4% year on year in the third quarter, Reuters reported.
The figure comes from a single Chinese drugmaker, so the release is unlikely to move broader markets.
why it matters
For investors in Shanghai Allist and China's pharmaceutical sector, the figure is a signal of the company's earnings momentum, though the news is limited to one issuer.
tags
instruments
sources
- Shanghai Allist Pharmaceuticals Q3 Net Profit Up 40.4% Y/Y — Reuters, 27 October 2026 at 09:27 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗